Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cell Transplantation | 10 | 2021 | 245 | 2.810 |
Why?
|
| Graft vs Host Disease | 5 | 2021 | 163 | 1.310 |
Why?
|
| Bone Marrow Transplantation | 2 | 2018 | 149 | 1.060 |
Why?
|
| Neutrophils | 2 | 2021 | 204 | 0.870 |
Why?
|
| Hematologic Neoplasms | 2 | 2021 | 37 | 0.850 |
Why?
|
| Febrile Neutropenia | 1 | 2021 | 5 | 0.800 |
Why?
|
| Phagocytes | 1 | 2021 | 15 | 0.790 |
Why?
|
| Ultraviolet Therapy | 1 | 2021 | 9 | 0.760 |
Why?
|
| Phototherapy | 1 | 2021 | 28 | 0.740 |
Why?
|
| Skin Diseases | 1 | 2021 | 122 | 0.670 |
Why?
|
| Child | 16 | 2023 | 6405 | 0.670 |
Why?
|
| Patient Discharge | 1 | 2021 | 294 | 0.660 |
Why?
|
| Neoplasms | 2 | 2021 | 1667 | 0.640 |
Why?
|
| Bone Marrow | 1 | 2018 | 168 | 0.600 |
Why?
|
| Transplantation, Homologous | 5 | 2021 | 242 | 0.580 |
Why?
|
| Child, Preschool | 10 | 2021 | 3187 | 0.570 |
Why?
|
| Pancytopenia | 2 | 2014 | 10 | 0.560 |
Why?
|
| Infant | 11 | 2021 | 2891 | 0.540 |
Why?
|
| Fever | 1 | 2016 | 96 | 0.520 |
Why?
|
| Graft Survival | 1 | 2018 | 465 | 0.520 |
Why?
|
| Hospitalization | 1 | 2021 | 978 | 0.520 |
Why?
|
| Copper | 2 | 2014 | 149 | 0.500 |
Why?
|
| Tetanus | 1 | 2014 | 11 | 0.490 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2014 | 15 | 0.490 |
Why?
|
| Folic Acid Antagonists | 1 | 2012 | 20 | 0.420 |
Why?
|
| Vitamin B Complex | 1 | 2012 | 26 | 0.410 |
Why?
|
| Adolescent | 11 | 2021 | 8912 | 0.410 |
Why?
|
| Leucovorin | 1 | 2012 | 35 | 0.410 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 58 | 0.400 |
Why?
|
| Methotrexate | 1 | 2012 | 91 | 0.400 |
Why?
|
| Wilms Tumor | 1 | 2010 | 47 | 0.370 |
Why?
|
| Retrospective Studies | 7 | 2021 | 7277 | 0.360 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 514 | 0.340 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2009 | 2 | 0.340 |
Why?
|
| Methemoglobinemia | 1 | 2009 | 6 | 0.340 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 446 | 0.340 |
Why?
|
| Sequence Deletion | 1 | 2009 | 89 | 0.330 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 206 | 0.330 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2021 | 116 | 0.320 |
Why?
|
| Vaccination | 1 | 2010 | 189 | 0.320 |
Why?
|
| Guideline Adherence | 1 | 2010 | 287 | 0.300 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 468 | 0.290 |
Why?
|
| Humans | 23 | 2023 | 68618 | 0.280 |
Why?
|
| Sucking Behavior | 1 | 2006 | 8 | 0.280 |
Why?
|
| Adrenoleukodystrophy | 1 | 2006 | 45 | 0.280 |
Why?
|
| Myasthenia Gravis | 1 | 2006 | 17 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2324 | 0.270 |
Why?
|
| Neurologic Examination | 1 | 2006 | 107 | 0.270 |
Why?
|
| Prognosis | 2 | 2021 | 2093 | 0.270 |
Why?
|
| Female | 14 | 2021 | 38074 | 0.250 |
Why?
|
| Point-of-Care Systems | 1 | 2006 | 115 | 0.250 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3259 | 0.240 |
Why?
|
| Transplantation Conditioning | 3 | 2021 | 34 | 0.240 |
Why?
|
| Young Adult | 4 | 2021 | 5717 | 0.230 |
Why?
|
| Male | 11 | 2021 | 37321 | 0.220 |
Why?
|
| Hematology | 1 | 2023 | 10 | 0.220 |
Why?
|
| Deglutition Disorders | 1 | 2006 | 297 | 0.210 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 17 | 0.210 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 127 | 0.200 |
Why?
|
| Consensus | 1 | 2021 | 211 | 0.180 |
Why?
|
| Diarrhea | 1 | 2020 | 63 | 0.180 |
Why?
|
| Acute Disease | 1 | 2021 | 658 | 0.160 |
Why?
|
| Unrelated Donors | 1 | 2018 | 4 | 0.160 |
Why?
|
| WT1 Proteins | 1 | 2018 | 5 | 0.160 |
Why?
|
| Antigens, CD34 | 1 | 2018 | 75 | 0.160 |
Why?
|
| Allografts | 2 | 2018 | 63 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2021 | 1342 | 0.150 |
Why?
|
| Blood Platelets | 1 | 2018 | 284 | 0.150 |
Why?
|
| Flow Cytometry | 1 | 2018 | 489 | 0.140 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2017 | 5 | 0.140 |
Why?
|
| Hepatitis | 1 | 2017 | 25 | 0.140 |
Why?
|
| Nevus, Pigmented | 1 | 2017 | 30 | 0.140 |
Why?
|
| Pediatrics | 1 | 2020 | 341 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 78 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 268 | 0.140 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2016 | 5 | 0.140 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2016 | 14 | 0.130 |
Why?
|
| Combined Modality Therapy | 2 | 2010 | 951 | 0.130 |
Why?
|
| Treatment Outcome | 3 | 2020 | 7029 | 0.120 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2014 | 21 | 0.120 |
Why?
|
| Lymphocyte Count | 1 | 2014 | 53 | 0.120 |
Why?
|
| Cataract | 1 | 2016 | 134 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 98 | 0.120 |
Why?
|
| Sarcoma, Ewing | 1 | 2014 | 26 | 0.120 |
Why?
|
| Heart Transplantation | 1 | 2017 | 328 | 0.110 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 100 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2077 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 375 | 0.110 |
Why?
|
| Thymectomy | 2 | 2017 | 11 | 0.110 |
Why?
|
| Mucositis | 1 | 2012 | 9 | 0.100 |
Why?
|
| Proteins | 1 | 2016 | 474 | 0.100 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2012 | 13 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2012 | 107 | 0.100 |
Why?
|
| Cyclosporine | 1 | 2012 | 121 | 0.100 |
Why?
|
| Melphalan | 1 | 2010 | 15 | 0.090 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2012 | 131 | 0.090 |
Why?
|
| Logistic Models | 1 | 2014 | 1420 | 0.090 |
Why?
|
| Etoposide | 1 | 2010 | 64 | 0.090 |
Why?
|
| Carboplatin | 1 | 2010 | 59 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2012 | 714 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 649 | 0.090 |
Why?
|
| Salvage Therapy | 1 | 2010 | 82 | 0.090 |
Why?
|
| Adult | 3 | 2021 | 21403 | 0.090 |
Why?
|
| Honduras | 1 | 2009 | 21 | 0.080 |
Why?
|
| Dyskinesias | 1 | 2009 | 8 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2009 | 45 | 0.080 |
Why?
|
| Neural Tube Defects | 1 | 2008 | 27 | 0.080 |
Why?
|
| Data Collection | 1 | 2010 | 420 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 208 | 0.080 |
Why?
|
| Vitamins | 1 | 2009 | 134 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 508 | 0.080 |
Why?
|
| Infant, Newborn | 3 | 2020 | 2455 | 0.080 |
Why?
|
| Heart Failure | 1 | 2017 | 1180 | 0.080 |
Why?
|
| Mothers | 1 | 2009 | 172 | 0.080 |
Why?
|
| Allergy and Immunology | 1 | 2006 | 9 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1851 | 0.070 |
Why?
|
| Plasmapheresis | 1 | 2006 | 18 | 0.070 |
Why?
|
| Pyridostigmine Bromide | 1 | 2006 | 11 | 0.070 |
Why?
|
| Antibody Formation | 1 | 2006 | 93 | 0.070 |
Why?
|
| Child Day Care Centers | 1 | 2006 | 25 | 0.070 |
Why?
|
| Pneumonia, Aspiration | 1 | 2006 | 22 | 0.070 |
Why?
|
| Muscle Fatigue | 1 | 2006 | 16 | 0.070 |
Why?
|
| Cholinergic Antagonists | 1 | 2006 | 17 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 80 | 0.070 |
Why?
|
| Neurology | 1 | 2006 | 43 | 0.070 |
Why?
|
| Airway Obstruction | 1 | 2006 | 49 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 597 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2006 | 222 | 0.070 |
Why?
|
| Time Factors | 1 | 2014 | 4655 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 349 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 504 | 0.070 |
Why?
|
| Complement System Proteins | 1 | 2006 | 135 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 772 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 579 | 0.060 |
Why?
|
| Recurrence | 1 | 2006 | 948 | 0.060 |
Why?
|
| Cytokines | 1 | 2006 | 866 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2023 | 110 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2006 | 468 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 132 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 214 | 0.050 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2020 | 6 | 0.050 |
Why?
|
| Cryptosporidiosis | 1 | 2020 | 7 | 0.050 |
Why?
|
| Cryptosporidium | 1 | 2020 | 9 | 0.050 |
Why?
|
| Sapovirus | 1 | 2020 | 7 | 0.050 |
Why?
|
| Feces | 1 | 2020 | 88 | 0.040 |
Why?
|
| Norovirus | 1 | 2020 | 31 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 492 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2020 | 110 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 33 | 0.040 |
Why?
|
| Mosaicism | 1 | 2017 | 21 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 94 | 0.030 |
Why?
|
| Lysosome-Associated Membrane Glycoproteins | 1 | 2016 | 6 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 15 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2016 | 17 | 0.030 |
Why?
|
| Sirolimus | 1 | 2017 | 118 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1603 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 2016 | 29 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 219 | 0.030 |
Why?
|
| Tacrolimus | 1 | 2017 | 127 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2016 | 87 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 329 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 2014 | 38 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 682 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2014 | 215 | 0.030 |
Why?
|
| Chromogranins | 1 | 2012 | 4 | 0.030 |
Why?
|
| Synaptophysin | 1 | 2012 | 16 | 0.030 |
Why?
|
| Vimentin | 1 | 2012 | 47 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 196 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 1515 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 1213 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 1056 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 306 | 0.020 |
Why?
|
| United States | 1 | 2023 | 7367 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2008 | 22 | 0.020 |
Why?
|
| Short Bowel Syndrome | 1 | 2008 | 15 | 0.020 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2008 | 37 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1070 | 0.010 |
Why?
|